Cara Therapeutics reported $21.4M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 146.91M 12.02M
Acelrx Pharmaceuticals ACRX:US $ 10.5M 37K
Aerie Pharmaceuticals AERI:US $ 61.69M 3M
Arena Pharmaceuticals ARNA:US $ 194.48M 50.09M
Biodelivery Sciences International BDSI:US $ 25.47M 4.6M
Cara Therapeutics CARA:US $ 21.4M 9.48M
Chugai Pharma 4519:JP 165.11B 40.41B
Depomed DEPO:US $ 19.54M 17.84M
Endo International Ordinary Shares ENDP:US $ 682.87M 112.15M
Halozyme Therapeutics HALO:US $ 40.24M 3.16M
Horizon Pharma HZNP:US $ 705.45M 11.42M
JAZZ PHA JAZZ:US $ 809.75M 11.66M
Johnson & Johnson JNJ:US $ 19.49B 2.84B
Neurocrine Biosciences NBIX:US $ 251.5M 25.4M
Pacira Pharmaceuticals PCRX:US $ 96.29M 4.46M
Pain Therapeutics PTIE:US $ 9.75M 4.62M
Pfizer PFE:US $ 16447M 3384M
Redhill Biopharma RDHL:US 46.39M 7.66M
Revance Therapeutics RVNC:US $ 92.47M 3.33M
Supernus Pharmaceuticals SUPN:US $ 115.86M 8.64M
Teva Pharmaceutical Industries TEVA:US 3.26B 64M
Vanda Pharmaceuticals VNDA:US $ 59.28M 3.75M